Select the Abstracts by Number

Click    to view the poster

677   Early Therapy with Ritonavir (RTV), ZDV and 3TC in HIV-1-Infected Children 1 24 Months of Age.

678   Evaluation of Toxicity, Tolerability and Antiviral Activity of Early d4T + ddI + Nelfinavir (NFV) Therapy in HIV-1 Vertically Infected Infants: 24-Week Preliminary Results from the PENTA 7 Study.

679   Is Simplification of HAART Safe in HIV-Infected Children? First Pediatric Switch Study.

680   Kaletra (Lopinavir/ Ritonavir) in HIV-Infected Children at 48 Weeks.

681   Safety and Antiviral Activity of Chronic Subcutaneous Administration of T-20 in HIV-1-Infected Children.

682   Efficacy and Tolerability of Efavirenz-Containing Regimen in Brazilian Children on Virological Failure to 2 Nucleoside Reverse Transcriptase Inhibitors (NRTI) with or without Protease Inhibitors (PI).

683   A Randomized Trial of Combination Therapy with Saquinavir Soft Gelatin Capsules (SQV) in HIV-Infected Children.

684   Virologic and Immunologic Responses in Children with Advanced HIV Disease on a New HAART Regimen (PACTG 366).

685   Comparison of HIV-1 Proviral DNA and Plasma RNA Genotyping and Its Utility in the Selection of Antiretroviral Therapy in Children.

685B   HIV-1 DNA Persists In PBMC of Children on HAART Despite Prolonged Suppression of Plasma HIV-1 RNA.